Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery
Clinical trial NCT05594290 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05594290
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2025-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.